explore -WSS

explore

author：knowledge 2025-09-29 18:15:57 - browse：93

Photo illustration with orange background of Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) -- biotech coverage from STAT — Desmond Padhi, PharmD, interim CEO, Latigo (center), with Latigo board chair Nancy Stagliano (left) and Westlake Village BioPartners founding managing director Sean Harper, M.D. (right) Illustration: Christine Kao/STAT; Courtesy: Steve Shoffner & Michael Haber

After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex Pharmaceuticals.

The startup is called Latigo Biotherapeutics, and it’s launching having already started a Phase 1 trial for a non-opioid pain medicine, LTG-001. The oral therapy is designed to silence pain-signaling neurons by blocking a sodium channel called NaV 1.8.

Westlake had set out years ago to scout out new options for pain medicines, and found a research desert, according to founding managing director Sean Harper. But NaV 1.8 has emerged as a promising option because of its potential to be non-addictive and to lessen pain without affecting a person’s central nervous system, digestion, or heart rate, as opioids can. There were still few high-quality molecules in development that could be licensed from an academic lab or another drug company, so Westlake decided to develop its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Delta passengers in Vegas fall sick while waiting on flight in triple

WSS

The EPA's new lead rule: How one expert crunched the numbers

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

How a Boston hospital is priming medical residents to use GPT

How a Boston hospital is priming medical residents to use GPT

5 dead in mass shooting on Caribbean island of St. Vincent: Police

The EPA's new lead rule: How one expert crunched the numbers

Wikipedia

explore

explore

Medical records are filled with copy

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

As demand for Covid shots wanes, Moderna seeks its next success

Cigna, Humana reportedly in talks to merge

Heart attack and stroke risk calculators need revising

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Hollywood unions extend contract negotiations for actors

What don’t we know about an Alzheimer’s drug side effect?

Medical leaders decry Supreme Court decision on affirmative action

BIO selects John Crowley as new CEO

hotspot

Dementia risk linked to living in disadvantaged areas: Study

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Delta passengers in Vegas fall sick while waiting on flight in triple

What don’t we know about an Alzheimer’s drug side effect?

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

focus

entertainment

hotspot

Wikipedia